Skip to main content

News

Active Pharmaceutical Ingredient (API) Prequalified

M
Announcement
11 November, 2026 - 00:12 (CET)

<Tenofovir disoproxil fumarate> manufactured by Viyash Scientific Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification proce

Update on Nitrosamine Impurities

M
Announcement
9 November, 2026 - 00:12 (CET)

In September 2023, WHO Prequalification Team - Medicines (PQT/MED) recognized new approaches to determine acceptable intakes (AIs) for nitrosamine impurities in medicines developed by medicines reg

Active Pharmaceutical Ingredient (API) Prequalified

M
Announcement
13 October, 2026 - 00:12 (CEST)

Abacavir (sulfate) (WHOAPI-516) manufactured by Viyash Scientific Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

PQT/AMD newsletter - Q3 2026, Issue 54 is now available

ID
IVD
MD
Announcement
30 September, 2026 - 17:11 (CEST)

We are pleased to share the latest edition of our newsletter, featuring recent updates, key developments, and other relevant information. 

We invite you to read the newsletter and sta

Active Pharmaceutical Ingredient (API) Prequalified

M
Announcement
17 September, 2026 - 12:12 (CEST)

Lamivudine manufactured by Jiangxi Desano Pharmaceutical Co. Ltd. has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

Active Pharmaceutical Ingredient (API) Prequalified

M
Announcement
16 September, 2026 - 12:12 (CEST)

Bedaquiline (fumarate) manufactured by Arene Life Sciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

New EUL listing

ID
IVD
Announcement
9 September, 2026 - 09:35 (CEST)

WHO has listed the QuantiVirus MPXV Test Kit, manufactured by DiaCarta Inc., under its Emergency Use Listing (EUL) procedure, expanding ac

New EUL listing

ID
IVD
Announcement
2 September, 2026 - 14:38 (CEST)

Effective outbreak control begins with accurate and timely diagnosis.

Active Pharmaceutical Ingredient (API) Prequalified

M
Announcement
24 August, 2026 - 00:12 (CEST)

Pyrazinamide manufactured by Resonance Specialities Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

2 additional tests listed under the EUL for IVDs

IVD
Announcement
7 August, 2026

The RealStar Filovirus Screen RT-PCR Kit 1.0, manufactured by Diagnostics GmbH, and the RADIONE Ebola/Marburg Detection Kit, manufactured by KH Medical Co., Ltd., have now received WHO Emergency Us

Active Pharmaceutical Ingredient (API) Prequalified

M
Announcement
31 July, 2026 - 12:12 (CEST)

Ritonavir manufactured by Qidong Dongyue Pharmaceutical Co., Ltd has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

WHO's Public Assessment Reports (WHOPAR) Update

ID
IVD
Alerts
24 July, 2026 - 17:26 (CEST)

Between 20 June and 21 July 2026, several WHO Public Assessment Reports (WHOPARs) were updated to reflect changes in product labelling, documentation, and other relevant post-prequ

WHO's Public Assessment Reports (WHOPAR) Update

IVD
Alerts
19 June, 2026 - 15:35 (CEST)

Between 27 May and 19 June 2026, several WHO Public Assessment Reports (WHOPARs) were updated to reflect changes in product labelling, documentation, and other relevant post-prequa